Pneumonia: Criteria for patient instability on hospital discharge

Chest

Volumn 134, Issue 3, 2008, Pages 595-600

  Capelastegui, Alberto ^a   España, Pedro P ^a   Bilbao, Amaia ^b   Martinez Vazquez, Marimar ^a   Gorordo, Inmaculada ^a   Oribe, Mikel ^a   Urrutia, Isabel ^a   Quintana, José M ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Instability on discharge; Longitudinal study; Pneumonia; Predictive models

Indexed keywords

ARTICLE; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 51549122085     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-3039     Document Type: Article

References (26)

1. Miller J, Petrie J. Development of practice guideline. Lancet 2000; 355:82-83
2. Marrie TJ, Lau CY, Wheeler SI, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283:749-755
3. Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax 2004; 59:364-366
4. Kosecoff J, Kahn KL, Rogers WH, et al. Prospective payment system and impairment at discharge: the "quicker-and-sicker" story revisited. JAMA 1990; 264:1980-1983
5. Halm EA, Mittman BS, Walsh MB, et al. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 2001; 16:599-605
6. Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998; 279:1452-1457
7. Halm EA, Fine MJ, Kapoor WN, et al. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med 2002; 162:1278-1284
8. Dagan E, Novack V, Porath A. Adverse outcomes in patients with community acquired pneumonia discharged with clinical instability from internal medicine department. Scand J Infect Dis 2006; 38:860-866
9. Montori V, Permanyer-Miralda G, Ferreire-Gonzalez I, et al. Validity of composite end points in clinical trials. BMJ 2005; 330:594-596
10. España PP, Capelastegui A, Quintana JM, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J 2003; 21:695-701
11. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
12. Lim WS, Van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382
13. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist 1970; 1:20-30
14. Sager MA, Franke T, Inouye SK, et al. Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med 1996; 156:645-652
15. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998; 279:1187-1193
16. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med 1997; 12:423-430
17. Covinsky KE, Palmer RM, Counsell SR, et al. Functional status before hospitalization in acutely ill older adults: validity and clinical importance of retrospective reports. J Am Geriatr Soc 2000; 48:164-169
18. Clermont G, Angus DC, Linde-Zwirble WT, et al. Does acute organ dysfunction predict patient-centered outcomes? Chest 2002; 121:1963-1971
19. Glynn P, Coakley R, Kilgallen I, et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999; 54:51-55
20. Taniguchi T, Koido Y, Aiboshi J, et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27:1262-1264
21. Capelastegui A, España PP, Quintana JM, et al. Improvement of process-of-care and outcomes after implementing a guideline for management of community-acquired pneumonia: a controlled before-and-after study. Clin Infect Dis 2004; 39:955-963
22. Capelastegui A, España PP, Quintana JM, et al. Evaluation of clinical practice in patients admitted with community-acquired pneumonia over a 4-year period. Arch Bronconeumol 2006; 42:283-289
23. Jasti H, Mortensen EM, Obrosky DS, et al. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 2008; 46:550-556
24. Herzog NS, Bratzler DW, Houck PM, et al. Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia. Am J Med 2003; 115:454-461
25. Naylor MD, Brooten D, Campbell R, et al. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 1999; 281:613-620
26. Sington JD, Cotrell BJ. Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings. J Clin Pathol 2002; 55:499-502